Cipher Pharmaceuticals (OTCMKTS:CPHRF) Shares Pass Above 50 Day Moving Average – What’s Next?

Cipher Pharmaceuticals Inc. (OTCMKTS:CPHRF) (TSE:CPH) passed above its 50-day moving average during trading on Wednesday . The stock has a 50-day moving average of $10.32 and traded as high as $10.42. Cipher Pharmaceuticals shares last traded at $10.24, with a volume of 27,932 shares.

Cipher Pharmaceuticals Price Performance

The company’s 50-day simple moving average is $10.32 and its 200-day simple moving average is $10.14.

About Cipher Pharmaceuticals

Cipher Pharmaceuticals Inc operates as a specialty pharmaceutical company in Canada. It offers Epuris (isotretinoin), an oral retinoid indicated for the treatment of severe nodular and/or inflammatory acne, acne conglobate, and recalcitrant acne; Actikerall, a topical solution indicated for the treatment of slightly palpable and/or moderately thick hyperkeratotic actinic keratosis (Grade I/II) of the face, forehead, and balding scalp; Ozanex for the topical treatment of impetigo; Vaniqa, a topical cream for the slowing of the growth of unwanted facial hair in women; Durela, an opioid analgesic for the management of moderate to moderately severe pain in adults; Brinavess for the rapid conversion of onset atrial fibriallation to sinus rhythm in adults; and Aggrastat, a reversible GP IIb/IIIa inhibitor for use in patients with Acute Coronary Syndrome.